Lv11
50 积分 2023-09-27 加入
Effectiveness and safety of once‐weekly subcutaneous semaglutide versus other glucose‐lowering agents in real‐world patients with type 2 diabetes: A retrospective, observational post‐marketing study
2天前
已完结
Compatibility of prolonged infusion antibiotics during Y‐site administration
4天前
已完结
Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States
17天前
已完结
Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy
19天前
已完结
Task force on management and prevention of Acinetobacter baumannii infections in the ICU
20天前
已完结
Sedatives in neurocritical care: the old, the new, the future
20天前
已完结
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
20天前
已完结
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia
3个月前
已关闭
Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia
3个月前
已关闭
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
1年前
已完结
皖公网安备34019202002308
